ViiV Healthcare is a pharmaceutical company specializing in the development of therapies for HIV infection that was created as a joint venture by Pfizer and GlaxoSmithKline in November 2009 with both companies transferring their HIV assets to the new company. In 2012 Shionogi joined the company.
Cabenuva: The First Long-Acting HIV Treatment🧬🧪💉
The first long-acting drug combination for HIV, to be administered monthly after the successful approval from the United States regulators. Thursday’s authorization of the two-shot combination, referred to as Cabenuva, is anticipated to make it less complicated for individuals to follow proper medication as well as to give more privacy.